← Securities 
◑ We're currently building out coverage for Swiss-listed stocks (SIX Exchange). Other markets will follow.
BioVersys AG
CH0210362643 · BIOVSIX · 🇨🇭 CH · Healthcare · Stock
BioVersys AG is a Swiss clinical-stage biopharmaceutical company headquartered in Basel, focused on developing novel antibacterial therapies to combat antimicrobial resistance. The company applies its proprietary transcription factor-targeting platform to discover and advance small-molecule drug candidates against difficult-to-treat bacterial infections. Its pipeline includes programs targeting pathogens such as Mycobacterium tuberculosis and multi-drug-resistant Gram-negative bacteria.
Last Dividend
—
CHF
5Y Growth
—
CAGR
Frequency
None
Years Paid
—
consecutive
Not Cut
—
consecutive yrs
Grown
—
consecutive yrs
Listings
| Exchange | Ticker | Currency |
|---|---|---|
| SIX primary | BIOV | CHF |
Annual Dividends
No dividend history available.
Dividend History
| Ex-Date ▼ | Pay-Date ▼ | Amount ▼ | Type ▼ |
|---|---|---|---|
| No dividend events found. | |||